Exemestane Tablet, Film Coated
Product Images NDC 59651-516

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 59651-516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Exemestane Fig1)

The given text presents some statistical measures related to disease-free survival. The HR (hazard ratio) at 85% is 0.69 with a 95% confidence interval of (0.58, 0.82). Moreover, the b(log-rank) score is 0.00003. The information is visualized in a graph depicting the duration of disease-free survival (months) for two randomized treatments, Eemestmne and Tamoxiten, with corresponding nEvents (number of events) and nPatients.*

FDA Label Image

Figure-2 (Exemestane Fig2)

FDA Label Image

Figure-3 (Exemestane Fig3)

Each tablet of Exemestane USP 25 mg is film-coated and distributed by Aurobindo Pharma USA, Inc. It comes in a pack of 30 tablets and should be stored between 20°C to 25°C (68°F to 77°F) with permitted excursions from 15°C to 30°C (59°F to 86°F). The usual dosage should be taken as per the accompanying prescription information. The drug is prescription-only and a control room temperature USP drug. The code on the tablet pack is TS/DRUGS/24/2015. The manufacturer is based in India.*

FDA Label Image

Str (Exemestane Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.